NEW YORK (GenomeWeb) – GenomeDx Biosciences has inked a research collaboration with Astellas to investigate use of its Decipher Classifier and Genomics Resource Information Database (GRID) to assess prostate cancer tumor aggressiveness and treatment response.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.